Version 2.77

Term Description

Qualitative detection of SARS-CoV-2 antibodies in a dried blood spot by an immunoassay method, such as enzyme-linked immunosorbent assay (ELISA), microsphere immunofluorescence-based assay (MIA), or electrochemiluminescence immunoassay (ECLIA).
Source: Regenstrief LOINC

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type Source Reference
Webcontent Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. Coronavirus (COVID-19) Testing

Fully-Specified Name

SARS coronavirus 2 Ab

Additional Names

Short Name
Display Name
SARS-CoV-2 (COVID-19) Ab IA Ql (DBS)
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) antibody, Dried blood spot

Example Answer List: LL4994-1

Source: Association of Public Health Laboratories
Answer Code Score Answer ID
NonreactiveCopyright ID:131194007 Non-reactive (qualifier value) LA15256-3
ReactiveCopyright ID:11214006 Reactive (qualifier value) LA15255-5

Basic Attributes

First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation

Member of these Panels

LOINC Long Common Name
96118-5 SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay

Member of these Groups Get Info

LOINC Group Group Name
LG51018-6 SARSCoV2 antibody detection

Language Variants Get Info

Tag Language Translation
de-DE German (Germany) SARS-Coronavirus 2 Ak:Nachweis oder Schwellenwert:Zeitpunkt:Blut.Tropfen:Ordinal:Immunoassay
es-ES Spanish (Spain) Panel del SARS-CoV-2 (COVID-19) Anticuerpos:PrThr:Punto temporal:gota de sangre (papel de filtro):Ord:IA
es-MX Spanish (Mexico) Coronavirus 2 Ab del SARS:Presencia o umbral:Punto temporal:DBS:Ordinal:Inmunoensayo
fr-CA French (Canada) coronavirus 2 du SRAS , Ac:Présence-Seuil:Temps ponctuel:Sang sur papier filtre:Ordinal:IA
fr-FR French (France) Coronavirus SARS-CoV-2 Ac:Présence/Seuil:Ponctuel:Sang buvard:Qualitatif:Immunoanalyse
it-IT Italian (Italy) SARS coronavirus 2 carta da filtro:Ord:IA
Synonyms: anticorpo Coronavirus della SARS Immunoassay Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Spot sangue secco
nl-NL Dutch (Netherlands) SARS-CoV-2 As:aanwezigheid:moment:gedroogde bloedspot:ordinaal:immunoassay
Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL Polish (Poland) SARS-CoV-2 Ab:granica wykrywalności:punkt w czasie:sucha kropla krwi:półilościowy:metoda immunologiczna
Synonyms: Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19)
zh-CN Chinese (China) SARS 冠状病毒 2 抗体:存在情况或阈值:时间点:全血.斑点:序数型:免疫测定法
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 依次型;分类顺序型;定性的;序数型(或称等级型);性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 全血斑点(滤纸);滤纸;血液.斑点;血液斑点(滤纸) 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况(存在、存在与否、是否存在)或阈值(界值、界限、阀值、临界值) 微生物学;微生物学试验;微生物学试验(培养、DNA、抗原及抗体) 时刻;随机;随意;瞬间 血;血液

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup$lookup?system=